The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:

The income statement for the year ended December 31, 20Y3, is as follows:

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: (1) The investments were sold for $175,000 cash. (2) Equipment and land were acquired for cash. (3) There were no disposals of equipment during the year. (4) The common stock was issued for cash. (5) There was a $90,000 debit to Retained Earnings for cash dividends declared.

Prepare a statement of cash flows, using the direct method of presenting cash flows from operating activities.

3,000,000 1,400,000 1,600,000 Cost of goods sold. Operating expenses: Other operating expenses. 950,000 1,050,000 550,000 Other income 75,000 625,000 125,000 500,000 Income before income tax Net income